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Abstract
Background and Purpose: Surgical management of a renal neoplasm in a solitary kidney is a balance between
oncologic control and preservation of renal function. We analyzed patients with a renal mass in a solitary kidney
undergoing nephron-sparing procedures to determine perioperative, oncologic, and renal functional outcomes.
Patients and Methods: A multicenter study was performed from 12 institutions. All patients with a functional or
anatomic solitary kidney who underwent nephron-sparing surgery for one or more renal masses were included.
Tumor size, complications, and recurrence rates were recorded. Renal function was assessed with serum
creatinine level and estimated glomerular filtration rate.
Results: Ninety-eight patients underwent 105 ablations, and 100 patients underwent partial nephrectomy (PN).
Preoperative estimated glomerular filtration rate (eGFR) was similar between the groups. Tumors managed with PN
were significantly larger than those managed with ablation (P < 0.001). Ablations were associated with a lower overall
complication rate (9.5% vs 24%, P = 0.01) and higher local recurrence rate (6.7% vs 3%, P = 0.04). Eighty-four patients
had a preoperative eGFR ‡ 60 mL/min/1.73 m2. Among these patients, 19 (23%) fell below this threshold after
3 months and 15 (18%) at 12 months. Postoperatively, there was no significant difference in eGFR between the groups.
Conclusions: Extirpation and ablation are both reasonable options for treatment. Ablation is more minimally
invasive, albeit with higher recurrence rates compared with PN. Postoperative renal function is similar in both
groups and is not affected by surgical approach.
Introduction
The surgical treatment of patients with an enhancingrenal mass in a solitary kidney presents a unique challenge
of maintaining adequate renal function while simultaneously
removing the tumor to provide oncologic control. Patients with
significant losses in renal function may need hemodialysis and
experience an increase in overall morbidity and mortality.1,2
Open partial nephrectomy (OPN) is the reference standard
for the management of a renal mass in a solitary kidney.3
1New York University School of Medicine, New York, New York.
2Department of Urology, Columbia University Medical Center, New York, New York.
3Department of Urology, University of Florida Medical Center, Gainesville, Florida.
4Department of Urology, University of Texas Southwestern Medical Center, Dallas, Texas.
5Department of Urology, University of California, Irvine, Orange, California.
6Department of Urology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
7Smith Institute for Urology, North Shore-LIJ Health System, New Hyde Park, New York.
8Department of Urology, Hackensack University Medical Center, Hackensack, New Jersey.
9Department of Urology, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin.
10Division of Urology, Duke University Medical Center, Durham, North Carolina.
11Section of Urology, University of Chicago Medical Center, Chicago, Illinois.
12Department of Urology, Ochsner Clinic Foundation, Baton Rouge, Louisiana.
13Department of Urology, University of Michigan Medical Center, Ann Arbor, Michigan.
JOURNAL OF ENDOUROLOGY
Volume 26, Number 10, October 2012




Minimally invasive approaches, however, such as laparo-
scopic partial nephrectomy (LPN), renal cryoablation, and
radiofrequency ablation (RFA), have been safely and effec-
tively performed in patients with a solitary kidney.4 In the
current study, we evaluated multicenter data on patients with
a functional or anatomic solitary kidney (congenital or ac-
quired) and a renal cortical neoplasm (RCN) who underwent
a nephron-sparing procedure (open or minimally invasive) to
assess perioperative data, oncologic outcomes, complications,
and the effects on renal function.
Patients and Methods
Study population
A retrospective multicenter study was performed collect-
ing data from 12 institutions. Institutional Review Board
approval was obtained from each institution before compiling
the patient data. All patients with a functional or anatomic
solitary kidney (congenital or acquired) who underwent
nephron-sparing surgery for one or more renal masses were
included. There was no standardized definition (estimated
glomerular filtration rate [eGFR]) of a nonfunctioning kidney.
Similarly, there was no standard test to diagnose a nonfunc-
tioning kidney. Patients with preexisting metastatic disease
were excluded from the study.
Study design
Procedures performed included OPN, LPN, laparoscopic
cryoablation (LCA), percutaneous cryoablation (PCA), and
RFA (laparoscopic and percutaneous). Clinical data, includ-
ing age, preoperative serum creatinine, tumor size, and sur-
gical approach, were recorded. Operative time, estimated
blood loss (EBL), length of hospital stay (LOS), and method
of vascular control of the hilum (when performed) were
documented. Histopathology was determined from either a
pretreatment biopsy (ablative treatments) or analysis of the
final surgical specimen. Ischemia times (warm vs cold),
complication rates (Clavien classification), tumor recurrences,
and renal function outcomes were documented.
Tumor persistence was defined as contrast enhancement of
the tumor bed on CT or MRI on the first postoperative
imaging study. Local recurrence was defined as tumor bed
enhancement on CT or MRI in patients who had previously
undergone postoperative imaging with negative results. Re-
nal function was measured by serum creatinine level and
eGFR on postoperative day 1 and at 1, 3, 6, and 12 months.
eGFR was calculated using the four variable Modification of
Diet in Renal Disease equation. Outcomes from patients after
ablative therapy (cryoablation and RFA) were compared with
those in patients undergoing extirpative surgery (OPN and
LPN). Similarly, patients undergoing OPN were compared
with those who underwent LPN.
Statistical analysis
Univariate analyses were performed with chi-square and t test
for categorical and continuous variables, respectively. For vari-
ables where the distribution did not conform to the normality
assumption, the Mann-Whitney and Kruskal-Wallis tests were
used. All statistical tests were two-sided, and a P value < 0.05 was
considered statistically significant. Statistical analysis was per-
formed using Stata v 9.0 software (College Station, TX).
Results
Between February 1998 and September 2010, a total of 205
procedures were performed for RCN in solitary kidneys.
There were 195 patients who had an anatomic solitary kidney
and 3 patients with a functional solitary kidney. Ninety-eight
patients underwent 105 ablation procedures, and 100 patients
underwent partial nephrectomy (PN) (50 OPN and 50 LPN).
Table 1 summarizes clinical, surgical, and perioperative data
comparing all forms of ablation with PN. Patients undergoing
PN had significantly larger tumors than patients having ab-
lation (mean of 3.9 cm vs 2.5 cm, P < 0.001) respectively.
EBL, LOS, and complication rates were significantly lower
for ablation procedures compared with PN. In the ablation
group, there was one case of inadvertent skin freezing during
an LCA. Postablation complications classified by the Clavien
system demonstrated five patients (grade I), one patient
(grade II), one patient (grade IIIa), and two patients with
(grade IIIb). Intraoperative complications in the PN group
consisted of four cases of severe intraoperative bleeding
necessitating transfusion, one renal artery injury, and one
pleural injury. Postoperative complications for PN included
10 patients with grade I, 2 patients with grade II, and 6
patients with grade IIIb complications.
Three (2.9%) patients had tumor persistence after ablation.
One patient underwent laparoscopic RFA with a salvage LCA
performed 1.5 months later. One patient had persistence after
PCA and was treated with repeated PCA, and one patient
underwent LCA and was treated with salvage laparoscopic
RFA. Postoperative imaging after salvage procedures dem-
onstrated no evidence of persistence or recurrence in any of
the patients.
There were nine (8.6%) recurrences after ablation (seven
local, two patients with metastatic disease). Five (56%) re-
currences were managed with a minimally invasive nephron-
sparing approach with no subsequent cancer recurrence. One
patient underwent an OPN and has had no evidence of re-
currence. The other patient initially underwent a percutane-
ous RFA and was subsequently treated with a laparoscopic
radical nephrectomy (LRN). Adrenal metastasis then devel-
oped in this patient. Two patients with metastatic recurrence
were managed by medical oncology. There were no cancer-
specific deaths in the group, and one patient death was from
an unrelated malignancy.
There were four recurrences after PN. Three (3%) were local
recurrences after OPN. One patient presented with a 7-cm
tumor and had a positive margin after OPN. This patient
underwent LRN and was placed on hemodialysis. Two pa-
tients were treated with a repeated nephron-sparing surgery
(OPN and laparoscopic RFA) and have had no evidence of
recurrence to date. A solitary metastatic liver lesion devel-
oped in one patient after an LPN for a 6.8-cm tumor. This
lesion was treated with surgical resection. There were four
(4%) deaths in the PN group that were all unrelated to renal-
cell carcinoma or chronic kidney disease.
Within the PN group, patients undergoing OPN were
compared with those undergoing LPN for differences in renal
function and oncologic outcomes (Table 2). The mean opera-
tive times, ischemia times, and EBL were significantly lower
for LPN compared with OPN; however, there was no statis-
tical difference in complication rates. LPN patients classified
by the Clavien system demonstrated six patients (grade I),
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# patients 98 100
# procedures 105 100 –
Mean age (years) (range) 64 (38–86) 64 (35–92) 0.85
Mean tumor size (cm) (range) 2.5(1–4.4) 3.9 (1–10) <0.001
Mean preoperative creatinine (mg/dL) 1.4 1.4 0.65
Side: # (%)
Left 48 (46) 42 (42) 0.39
Right 50 (48) 56 (56)
Unknown 7 (6) –
Mean operative time (min)(range) 155 (69–300) 169 (68–270) 0.10
Median EBL (mL)(range) 50 (5–400) 400 (25–3900) <0.001
Pathology: # (%)
Clear–cell 51 (49) 70 (70)
Papillary 5 (4.7) 18 (18)
Chromophobe – 6 (6)
Oncocytoma 13 (12) 3 (3) –
AML 6 (5.7) 3 (3)
Nondiagnostic 8 (7.6) –
No biopsy 22 (21) –
Mean length of stay (days)(range) 1.7 (1–8) 4.1 (1–21) <0.001
# Intraoperative complications (%) 1 (1) 6 (6) 0.16
# Postoperative complications (%) 9 (8.6) 18 (18) 0.05
Mean follow-up (months) 31 24 0.04
# Tumor persistence 3 (2.9) 0 0.25
# Local recurrences (%) 7 (6.7) 3 (3) 0.04
# Metastasis 2 (1.9) 1 (1) 0.33
# Deaths (%) 0 (0) 1 (1) 0.50
EBL = estimated blood loss; AML = acute myeloid leukemia.
Table 2. Open Partial Nephrectomy versus Laparoscopic Partial Nephrectomy:
Clinical, Surgical, and Pathologic Outcomes
Variable OPN LPN P value
Number 50 50 –
Mean tumor size (cm) (range) 4.3 (1.6–10) 3.6 (1–9.2) 0.13
Mean preoperative creatinine (mg/dL) 1.4 1.4 0.52
Side: # (%)
Left 21 (42) 21 (42) 0.86
Right 27 (54) 29 (58)
Cold ischemia:
No 18 (36) 50 (100) –
Yes 32 (64) –
Mean ischemia time (min)(range) 35 (0–91) 22 (0–40) <0.001
Mean operative time (min)(range) 190 (68–270) 152 (91–268) 0.001
Median EBL (mL)(range) 250 (75–3000) 175 (25–3900) 0.01
Pathology: # (%)
Clear-cell 40 (80) 30 (60)
Papillary 7 (14) 11 (22)
Chromophobe 3 (6) 4 (8) 0.07
Oncocytoma – 3 (6)
AML – 2 (4)
# positive margins (%) 8 (16) 1 (2) 0.01
# Intraoperative complications (%) 4 (8) 2 (4) 0.68
# Postoperative complications (%) 8 (16) 10 (20) 0.80
Mean follow-up (months) 23 25 0.59
# Local recurrences (%) 3 (6) 0 0.24
# Metastasis 0 1 (2) 1.0
OPN = open partial nephrectomy; LPN = laparoscopic partial nephrectomy; EBL = estimated blood loss; AML = acute myeloid leukemia.
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two patients (grade II), and two patients (grade IIIb). OPN
patients had four patients with grade I, two patients with
grade II, and two patients with grade IIIb (Table 3).
There was no statistically significant difference in the eGFR
preoperatively or postoperatively when comparing PN and
ablation (Table 4). Similarly, there was no significant differ-
ence when comparing OPN vs LPN (Table 5). We evaluated
all patients with a preoperative eGFR greater than 60 mL/
min/1.73 m2 in whom a drop below 60 mL/min/1.73 m2
developed after treatment of their renal mass. Twenty-three
percent (19/84) patients fell below 60 mL/min/1.73 m2 after
3 months and 18% after 12 months. Next, differences in eGFR
were determined based on tumor size. In patients who un-
derwent ablation, 32% who had a tumor size of < 4 cm de-
creased to an eGFR below 60 mL/min/1.73 m2. In patients
with a tumor size ‡ 4 cm, 50% fell below this level (P = 0.60). In
PN patients, 27% with a tumor < 4 cm and 36% with a tumor
‡ 4 cm dropped below 60 mL/min/1.73 m2 (P = 0.60).
Two (1%) patients with initial end-stage renal disease
(preoperative eGFR of < 15 mL/min/1.73 m2) underwent
nephron-sparing surgery. There was only one patient with a
preoperative eGFR > 15 mL/min/1.73 m2 who dropped be-
low this level to be considered end stage (preoperative eGFR
of 16 dropped to 7.85 mL/min/1.73 m2 after OPN).
Renal function after extirpative and ablative therapies was
compared after stratifying by acquired vs congenital solitary
kidneys. In both the ablation and PN groups, there was no
statistically significant difference in eGFR between congenital
and acquired solitary kidneys (P = 0.31 and P = 0.26).
Discussion
Patients with a renal mass in a solitary kidney represent
an imperative need for a nephron-sparing procedure. Con-
sequences of nephron loss include reduced renal function and
a decrease in a patient’s overall health. Go and colleagues2
demonstrated that a decrease in GFR independently pre-
dicted for an increase in hospitalization, cardiovascular re-
lated events, and mortality.
Nephron-sparing surgery performed in a solitary kidney
represents an excellent model for accurately assessing
changes in renal function. Historically, patients with solitary
kidneys have been able to maintain renal function after
nephron-sparing procedures. Fergany and colleagues3 re-
ported on 400 solitary kidney patients with a renal mass
treated with OPN. After a mean follow-up of 44 months,
function was preserved without the need for dialysis in 95.5%
of patients. OPN is the primary NSS option performed for
patients with a solitary kidney; however, minimally invasive
techniques, such as LPN, cryoablation, and RFA, have been
implemented as well. Turna and coworkers4 presented
outcomes after minimally invasive therapy in a cohort of 101
patients with a solitary kidney. Patients underwent LPN,
LCA, or percutaneous RFA. eGFR at 6 months revealed that
function decreased in 89%, 72.2%, and 55.2% with LPN, LCA,
and percutaneous RFA, respectively. Preoperative eGFR and
procedure type were significant independent predictors of
decreased renal function. Two (5.6%) patients remained on
permanent dialysis after LPN, while no patients in the LCA or
RFA groups needed dialysis.4
Renal ischemia is a known factor leading to the cellular
degeneration of nephrons and a decrease in overall renal
function after PN. La Rochelle and coworkers5 followed 84
patients who underwent OPN in a solitary kidney. Patients
either were exposed to no ischemia, warm ischemia, or cold
ischemia. Although the immediate eGFR decrease in patients
without clamping was lower than with either type of ischemia
(P < 0.001), eGFR 1 month later was not significantly different
between the three groups (P = 0.17). A multi-institutional







IIIa Hypervolemia/congestive heart failure
requiring radiologic intervention (1)
None
IIIb Urine leak requiring ureteral stent (2) Open conversion (1)
Clot retention with irrigation (1)
Urine leak requiring ureteral stent (4)
Table 4. Postoperative Serum Creatinine, % Change
in Postoperative Serum Creatinine,
and Estimated Glomerular Filtration Rate








Preoperative 59 59 0.91
3 months 52 53 0.76
12 months 51 52 0.78
Calculated using Mean Modification of Diet in Renal Disease
equation.
GFR = glomerular filtration rate.
Table 5. Postoperative Serum Creatinine, % Change
in Postoperative Serum Creatinine,
and Estimated Glomerular Filtration Rate










(mL/min/1.73 m2) P values
Pre-operative 57 60 0.56
3 months 50 54 0.50
12 months 50 52 0.65
Calculated using Mean Modification of Diet in Renal Disease
equation.
GFR = glomerular filtration rate.
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study observed factors predicting renal function after OPN in
a solitary kidney under both cold and warm ischemia. Warm
ischemia was performed in 360 cases and cold ischemia in 300
cases with a mean follow-up of 2.6 years. Three months after
OPN, the median eGFR decreased by a similar rate in both
groups (cold 21% and warm 2%, P = 0.7). On multivariable
analysis, the strongest independent predictors of renal func-
tion were preoperative eGFR and the estimated percentage of
parenchyma spared (P = 0.00001). Percentage of parenchyma
spared, however, was only subjectively assessed during sur-
gery. The type and duration of ischemia were not statistically
significant predictors of postoperative eGFR.6
Ablative procedures are associated with lower complica-
tion rates and higher recurrence rates relative to extirpative
procedures.7 Kunkle and colleagues8 reported recurrence
rates in 1375 tumors treated with either cryoablation (5.2%) or
RFA (12.9%).8 In the current study, ablation procedures also
had a significantly higher local recurrence rate compared with
PN (6.7% vs 3%, P = 0.04). In this study, patients undergoing
PN had larger and possibly more complex tumors. This pro-
vides additional evidence that PN seems to have an advan-
tage over ablation in terms of recurrence rates. It should be
stated, however, that the current study was not sufficiently
powered to make definitive conclusions about recurrence-free
survival or disease-specific survival.
Patients undergoing LPN had significantly shorter ische-
mia times, operative times, and less blood loss compared with
OPN patients. In addition, patients also had a lower positive
margin rate and recurrence rate compared with OPN. While
LPN is a reasonable treatment approach in patients with a
solitary kidney, these findings are likely a function of patient
selection. Patients undergoing OPN may have had tumors
that were more complex (endophytic or hilar). Data to stratify
tumors by complexity were not available for analysis.
Previous data have associated LPN with a higher compli-
cation rate compared with OPN.9,10 In the current study, there
were no differences in complication rates between OPN and
LPN (P = 1.0). Case selection may contribute to these results;
however, this study is limited in that it did not analyze or
stratify tumors by complexity.
We found no significant change in eGFR from preoperative
values to those obtained 3 and 12 months after either PN or
ablation. We did notice, however, a significantly lower post-
operative day 1 serum creatinine level in ablation vs PN
(P = 0.0002) and in LPN vs OPN (P = 0.005). There are several
factors that may contribute to this transient change, such as
the method of hilar clamping, patient hydration, diuretic ad-
ministration, and anesthesia effects. There was no long-term
difference in either serum creatinine level or eGFR, however.
There were 9.6% of patients who had a congenital solitary kid-
ney (4.1% ablation, 15% LPN). We hypothesized that congenital
solitary kidneys would be larger and more robust compared
with solitary kidneys that are acquired, and therefore these pa-
tients would have a higher renal reserve before surgery and have
less damage to their kidney postoperatively. Because of the
limited number of patients, however, we are unable to establish
any definitive conclusions regarding this group of patients.
Limitations include a nonrandomized retrospective design
and variability with how procedures were performed de-
pending on institution. There was no standardization with
surgical technique, ablation protocols (equipment, number of
treatment probes, and duration of ablation), type of hilar
clamping, or definition of operative time. We did not quantify
tumor complexity with a standardized system (such as
R.E.N.A.L. [radius; exophytic/endophytic; nearness; anterior/
posterior; location] nephrometry score) nor did we have a sys-
tem for determining the volume or percent of renal parenchyma
that was spared after PN or ablation. This would have provided
value in determining how patients were selected for treatment.
Patients undergoing ablation had significantly smaller tumors
compared with those who underwent PN, and follow-up for
both the PN and ablation cohorts was relatively short.
Local recurrence was defined as tumor bed enhancement
after cross-sectional imaging with intravenous contrast in
patients who had previously had an unenhanced tumor bed.
This designation may have artificially inflated the number of
recurrences because none of these patients underwent a post-
treatment biopsy. In addition, the exact date of the tumor
recurrences is not known; therefore, we are unable to identify
at what point recurrences occurred. Lastly, we were unable to
make any substantial conclusions regarding differences in
function between congenital and acquired solitary kidneys
because of the small number in each group (n = 19).
Conclusions
For patients with a solitary kidney, PN and ablation are
both reasonable treatment options. Postoperative renal func-
tion appears to be similar for either surgical or ablative
treatment based on eGFR and is not affected by surgical ap-
proach to PN (OPN vs LPN). Ablative therapy may offer
improved short-term benefits; however, our data demon-
strated that recurrence rates were higher with ablation com-
pared with PN. LPN demonstrated shorter ischemia times
compared with OPN and exhibited no significant change in
complication or recurrence rates.
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EBL¼ estimated blood loss
eGFR¼ estimated glomerular filtration rate
LCA¼ laparoscopic cryoablation
LOS¼ length of stay
LPN¼ laparoscopic partial nephrectomy
LRN¼ laparoscopic radical nephrectomy
MRI¼magnetic resonance imaging
OPN¼ open partial nephrectomy
PCA¼percutaneous cryoablation
PN¼partial nephrectomy
RCN¼ renal cortical neoplasm
RFA¼ radiofrequency ablation
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